117 related articles for article (PubMed ID: 18351130)
1. Antisense experiments demonstrate an exon 4 minus splice variant mRNA as the basis for expression of tNOX, a cancer-specific cell surface protein.
Tang X; Morré DJ; Morré DM
Oncol Res; 2007; 16(12):557-67. PubMed ID: 18351130
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing as the basis for specific localization of tNOX, a unique hydroquinone (NADH) oxidase, to the cancer cell surface.
Tang X; Tian Z; Chueh PJ; Chen S; Morré DM; Morré DJ
Biochemistry; 2007 Oct; 46(43):12337-46. PubMed ID: 17924659
[TBL] [Abstract][Full Text] [Related]
3. tNOX is both necessary and sufficient as a cellular target for the anticancer actions of capsaicin and the green tea catechin (-)-epigallocatechin-3-gallate.
Chueh PJ; Wu LY; Morré DM; Morré DJ
Biofactors; 2004; 20(4):235-49. PubMed ID: 15706060
[TBL] [Abstract][Full Text] [Related]
4. Catechin-vanilloid synergies with potential clinical applications in cancer.
Morré DM; Morré DJ
Rejuvenation Res; 2006; 9(1):45-55. PubMed ID: 16608395
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal relationship between cytosolic NADH and ENOX2 inhibition triggers sphingolipid-induced apoptosis in HeLa cells.
De Luca T; Morré DM; Morré DJ
J Cell Biochem; 2010 Aug; 110(6):1504-11. PubMed ID: 20518072
[TBL] [Abstract][Full Text] [Related]
6. hnRNP F directs formation of an exon 4 minus variant of tumor-associated NADH oxidase (ENOX2).
Tang X; Kane VD; Morré DM; Morré DJ
Mol Cell Biochem; 2011 Nov; 357(1-2):55-63. PubMed ID: 21625959
[TBL] [Abstract][Full Text] [Related]
7. Mouse embryonic fibroblast cells from transgenic mice overexpressing tNOX exhibit an altered growth and drug response phenotype.
Yagiz K; Wu LY; Kuntz CP; James Morré D; Morré DM
J Cell Biochem; 2007 May; 101(2):295-306. PubMed ID: 17115410
[TBL] [Abstract][Full Text] [Related]
8. Is the cancer protective effect correlated with growth inhibitions by green tea (-)-epigallocatechin gallate mediated through an antioxidant mechanism?
Cutter H; Wu LY; Kim C; Morré DJ; Morré DM
Cancer Lett; 2001 Jan; 162(2):149-54. PubMed ID: 11146219
[TBL] [Abstract][Full Text] [Related]
9. Transgenic mouse line overexpressing the cancer-specific tNOX protein has an enhanced growth and acquired drug-response phenotype.
Yagiz K; Morré DJ; Morré DM
J Nutr Biochem; 2006 Nov; 17(11):750-9. PubMed ID: 16517149
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody to a cancer-specific and drug-responsive hydroquinone (NADH) oxidase from the sera of cancer patients.
Cho N; Chueh PJ; Kim C; Caldwell S; Morré DM; Morré DJ
Cancer Immunol Immunother; 2002 May; 51(3):121-9. PubMed ID: 11941450
[TBL] [Abstract][Full Text] [Related]
11. tNOX, an alternative target to COX-2 to explain the anticancer activities of non-steroidal anti-inflammatory drugs (NSAIDS).
Morré DJ; Morre DM
Mol Cell Biochem; 2006 Feb; 283(1-2):159-67. PubMed ID: 16444599
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of a tumor-associated NADH oxidase (tNOX) from the HeLa cell surface.
Yantiri F; Morré DJ
Arch Biochem Biophys; 2001 Jul; 391(2):149-59. PubMed ID: 11437345
[TBL] [Abstract][Full Text] [Related]
13. Effect of Ccapsaicin on tNOX (ENOX2) protein expression in stomach cancer cells.
Wang HM; Chueh PJ; Chang SP; Yang CL; Shao KN
Biofactors; 2008; 34(3):209-17. PubMed ID: 19734122
[TBL] [Abstract][Full Text] [Related]
14. Regulation of tNOX expression through the ROS-p53-POU3F2 axis contributes to cellular responses against oxaliplatin in human colon cancer cells.
Chen HY; Islam A; Yuan TM; Chen SW; Liu PF; Chueh PJ
J Exp Clin Cancer Res; 2018 Jul; 37(1):161. PubMed ID: 30029680
[TBL] [Abstract][Full Text] [Related]
15. ECTO-NOX target for the anticancer isoflavene phenoxodiol.
Morré DJ; Chueh PJ; Yagiz K; Balicki A; Kim C; Morré DM
Oncol Res; 2007; 16(7):299-312. PubMed ID: 17518268
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of tumor-associated NADH oxidase, tNOX (ENOX2), enhances capsaicin-induced inhibition of gastric cancer cell growth.
Wang HM; Chuang SM; Su YC; Li YH; Chueh PJ
Cell Biochem Biophys; 2011 Nov; 61(2):355-66. PubMed ID: 21735133
[TBL] [Abstract][Full Text] [Related]
17. Cell size increased in tissues from transgenic mice overexpressing a cell surface growth-related and cancer-specific hydroquinone oxidase, tNOX, with protein disulfide-thiol interchange activity.
Yagiz K; Snyder PW; Morré DJ; Morré DM
J Cell Biochem; 2008 Dec; 105(6):1437-42. PubMed ID: 18980249
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated NADH oxidase (tNOX)-NAD+-sirtuin 1 axis contributes to oxaliplatin-induced apoptosis of gastric cancer cells.
Chen HY; Cheng HL; Lee YH; Yuan TM; Chen SW; Lin YY; Chueh PJ
Oncotarget; 2017 Feb; 8(9):15338-15348. PubMed ID: 28122359
[TBL] [Abstract][Full Text] [Related]
19. RNA interference targeting tNOX attenuates cell migration via a mechanism that involves membrane association of Rac.
Liu SC; Yang JJ; Shao KN; Chueh PJ
Biochem Biophys Res Commun; 2008 Jan; 365(4):672-7. PubMed ID: 18023414
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and characterization of a tumor-associated, growth-related, and time-keeping hydroquinone (NADH) oxidase (tNOX) of the HeLa cell surface.
Chueh PJ; Kim C; Cho N; Morré DM; Morré DJ
Biochemistry; 2002 Mar; 41(11):3732-41. PubMed ID: 11888291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]